Human Movement Sciences, Old Dominion University, Norfolk, Virginia 23529, USA.
Clin J Sport Med. 2011 Nov;21(6):474-9. doi: 10.1097/JSM.0b013e3182340199.
OBJECTIVE: To determine the effects of augmented low-dye (ALD) taping and a heel-pain orthosis (HPO) on pain, peak plantar pressure (PPP), and mean plantar pressure (MPP) while walking and jogging. DESIGN: Cross-over study design. SETTING: University clinical laboratory. PARTICIPANTS: Seventeen physically active or sedentary individuals with plantar fasciitis. INTERVENTIONS: Both PPP and MPP were evaluated after 45 seconds of walking and jogging during the 3 interventions (control, ALD, HPO) under 4 areas of the foot: lateral rearfoot and forefoot, and medial rearfoot and forefoot. Pain was assessed during each intervention (at 60-second mark) using the visual analog scale (VAS). MAIN OUTCOME MEASURES: Peak plantar pressure, MPP, and VAS. RESULTS: The ALD produced a decrease in walking MPP (44.66 ± 14.46) under the lateral rearfoot compared with the control (57.92 ± 22.18; P = 0.024) and in jogging MPP (55.05 ± 18.27) compared with the control (67.22 ± 20.95; P = 0.002) and HPO (68.51 ± 17.57; P = 0.002). Scores of VAS decreased with the application of HPO (7.12 ± 10.08; P < 0.002 and 12.15 ± 15.61; P < 0.003) and ALD (6.24 ± 5.71; P < 0.006 and 10.09 ± 8.87; P < 0.001) while walking and jogging when compared with the control (17.32 ± 17.86 and 26.65 ± 22.38). CONCLUSIONS: Although the HPO and ALD produced statistically and clinically decreased VAS scores while walking and jogging, further research is needed beyond these preliminary findings to determine long-term outcomes related to pain relief.
目的:确定增强低染料(ALD)贴扎和足跟痛矫形器(HPO)在行走和慢跑时对疼痛、峰值足底压力(PPP)和平均足底压力(MPP)的影响。
设计:交叉研究设计。
设置:大学临床实验室。
参与者:17 名患有足底筋膜炎的活跃或久坐的个体。
干预措施:在 4 种足部区域(外侧足跟和前足,内侧足跟和前足)下,在 3 种干预措施(对照、ALD、HPO)下行走和慢跑 45 秒后,评估 PPP 和 MPP。在每个干预措施期间(在 60 秒标记时)使用视觉模拟量表(VAS)评估疼痛。
主要观察指标:峰值足底压力、MPP 和 VAS。
结果:ALD 在外侧足跟下行走时 MPP(44.66 ± 14.46)与对照组(57.92 ± 22.18;P = 0.024)相比降低,在慢跑时 MPP(55.05 ± 18.27)与对照组(67.22 ± 20.95;P = 0.002)和 HPO(68.51 ± 17.57;P = 0.002)相比降低。HPO 应用时 VAS 评分降低(7.12 ± 10.08;P < 0.002 和 12.15 ± 15.61;P < 0.003)和 ALD(6.24 ± 5.71;P < 0.006 和 10.09 ± 8.87;P < 0.001),行走和慢跑时与对照组(17.32 ± 17.86 和 26.65 ± 22.38)相比。
结论:尽管 HPO 和 ALD 在行走和慢跑时产生了统计学和临床上降低的 VAS 评分,但需要进一步的研究来确定与疼痛缓解相关的长期结果。
BMC Musculoskelet Disord. 2006-8-9
J Athl Train. 2007
J Orthop Translat. 2019-8-7